Advertisement · 728 × 90
#
Hashtag
#IDWeek2023
Advertisement · 728 × 90
Post image

Mentorship matters.

So proud of my mentees presenting at IDWeek this year.

#IDWeek2023

1 0 1 0
Preview
Is #IDWeek Community Leaving X? | Everyday Is A School Day Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it's clear we haven't lost our spark. Our ID community is still here, sha...

Is #IDweek Community Leaving X?
Not yet! After digging into both #IDWeek2023 and #IDWeek2024 tweets data, and crunching some numbers to compare user activity, it’s clear we haven’t lost our spark.
www.kenkoonwong.com/blog/idweek_...

0 0 0 0
Post image

✔ REMINDER | Webinar TOMORROW | 11/16/23 at 1:00pm EST.

Don't forget to REGISTER 👇 & add it to your calendar! attendee.gotowebinar.com/register/258...

🙋‍♀️❓🙋‍♂️ Stay for the Q&A
Topics include but not limited to:
· CMV, HIV, & hepatitis-C in transplantation & Covid-19

#idweek2023 #ganciclovir #CMV

2 0 0 0
Preview
Screening and Early Treatment for Anal Cancer in People With HIV Topical treatment may be as effective as electrocautery for anal neoplasia but with fewer adverse effects.

News from #IDWeek2023 & #EACS2023: #HIV+ people treated with trichloroacetic acid were about as likely to experience improvement of precancerous anal cell lesions as those who underwent electrocautery, but were less likely to experience side effects. 1/

0 0 1 0
Preview
Liver Cancer Declined After Advent of Hepatitis C Treatment Hepatocellular carcinoma among people with HCV fell after the debut of direct-acting antivirals, but cases are rising for other groups.

News from #IDWeek2023: After rising for over a decade, new cases of liver cancer began to decline among people with #hepatitisC in NYC after the advent of effective antiviral treatment. But many people are not aware they carry HCV & only a third have been successfully treated.

0 0 0 0
Preview
Sunlenca Remains Active Against Drug-Resistant HIV After two years on lenacapavir, people with advanced immune suppression experienced substantial gains in CD4 T cells.

News from #IDWeek2023 & #EACS2023: Sunlenca (lenacapavir) remains active at 2 years in people with resistant #HIV, mostly mild to moderate injection site reactions, proportion with CD4 count <200 fell from 64% at baseline to 29%.

1 0 0 0
Post image

A gift to myself while at #IDWeek2023

Motivated for work, patient care, research & running after getting back from Boston

The TC Marathon was canceled the morning of on 10/1. Maybe 1 day I can cross the finish on #Boylston

#IDSky
#RunTheSky

5 1 0 0
Post image

First and foremost, #IDWeek2023 was amazing & ID docs are the best!

Missing all you amazing folks out there! See you in LA!

2 0 0 0
Preview
PEP-in-Pocket Is Another Option for HIV Prevention Providing a course of antiretrovirals to use after infrequent HIV exposures could lower cost and remove barriers to access.

News from #IDWeek2023: Having antiretrovirals on hand to take after infrequent exposures—an approach dubbed PEP-in-pocket, or PIP—is a feasible #HIV prevention option.

0 0 0 0
Preview
Das Coronavirus infiziert den männlichen Genitaltrakt: Neue Studie zeigt direkte Auswirkungen von C... DMZ – WISSENSCHAFT ¦ Anton Aeberhard ¦ Eine neue Studie der Feinberg School of Medicine an der Northwestern University zeigt, dass verschiedene Gewebe des männlichen Genitaltrakts mit dem SARS-Co...

Das Coronavirus infiziert den männlichen Genitaltrakt: Neue Studie zeigt direkte Auswirkungen von COVID-19 auf die männliche Gesundheit www.dmz-news.eu/2023/10/16/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff

71 45 6 4
Preview
Die Wirksamkeit von COVID-19-Impfungen bei der Verhinderung von post-COVID-Bedingungen DMZ – FORSCHUNG ¦ Lena Wallner ¦ Eine systematische Literaturübersicht und Meta-Analyse der neuesten Forschung Eine kürzlich durchgeführte systematische Literaturübersicht und Meta-Analyse hat...

Die Wirksamkeit von COVID-19-Impfungen bei der Verhinderung von post-COVID-Bedingungen www.dmz-news.eu/2023/10/14/d... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff

25 8 0 0
Post image

Just published online first in JAMA & presented #IDWeek2023

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection: The ACORN Randomized Clinical Trial

jamanetwork.com/journals/jam...

4 1 0 2
Preview
Fortschritte in der Erforschung der SARS-CoV-2-Infektionen DMZ – FORSCHUNG ¦ Lena Wallner ¦ Die kürzlich veröffentlichte Studie "Viral kinetics of sequential SARS-CoV-2 infections" hat uns spannende Erkenntnisse darüber geliefert, wie aufeinanderfolgen...

Fortschritte in der Erforschung der SARS-CoV-2-Infektionen www.dmz-news.eu/2023/10/14/f... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff

30 8 1 0
Preview
COVID-19 Intranasal Vaccine Candidate Produces Robust Immune Response The live-attenuated vaccine aims to produce an immune response to the entire virus rather than the frequently mutating spike protein.

News from #IDWeek: Experimental intranasal #COVID vaccine targets entire virus rather than just spike protein, which could provide broader protection against viral variants. #IDWeek2023

9 4 0 1
Preview
Reminder: Langzeitfolgen von SARS-Überlebenden: 18-jährige Studie liefert Einsichten DMZ – WISSENSCHAFT ¦ Sarah Koller ¦ In den letzten zwei Jahrzehnten haben Coronaviren (CoVs) mehrere Pandemien verursacht, darunter das schwere akute Atemwegssyndrom (SARS), das Middle East Respir...

Reminder: Langzeitfolgen von SARS-Überlebenden: 18-jährige Studie liefert Einsichten www.dmz-news.eu/2023/10/14/r... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff

36 12 1 1
Preview
Codagenix präsentiert auf IDWeek 2023 ermutigende klinische Daten für COVID-19-Impfstoffkandidaten... DMZ – FORSCHUNG ¦ Lena Wallner ¦ Codagenix Inc., ein biotechnologisches Unternehmen im klinischen Stadium mit einer innovativen Plattform für die Gestaltung viraler Impfstoffe und Therapeutika in...

Codagenix präsentiert auf IDWeek 2023 ermutigende klinische Daten für COVID-19-Impfstoffkandidaten CoviLiv www.dmz-news.eu/2023/10/13/c... #Covid #Covid19 #Covid_19 #SARSCoV2 #Corona #CovidIsNotOver #LongCovid #Pandemie #Studie #Impfung #CoviLiv #IDWeek2023 #Impfstoff

23 11 0 0
IDWeek 2023 Photo Gallery IDWeek 2023 Photo Gallery

Count the masks. #IDWeek2023

kellipricephotography.shootproof.com/gallery/idwe...

21 5 6 0

3 bhattacharyyalab.org posters today @ #IDWeek2023!

#250 PierreAnkomah: kinetics of a novel monocyte subtype in sepsis, implications for immunopathology

#623 Eleanor Young: a promising approach to fungal diagnostics

#875 David Roach: democratizing AMR diagnostics

Stop by!

2 0 0 1

Grant application submitted. Now off to Boston for #IDWeek2023

0 0 0 0